Posted on December 7, 202212/7/22
Seven Important Factors for APAC Companies to Consider while Launching Products in the Digital Health and Digital Therapeutics Space
Posted on November 22, 202211/22/22
Ready or Not, Biosimilar Adalimumab Brings the Heat in 2023
Posted on November 13, 202211/13/22
Establishing the Patient Access Mission During Clinical Development
Posted on November 10, 202211/10/22
Regulatory Framework for Digital Therapeutics in the APAC Region
Posted on November 3, 202211/3/22
Emerging Trends in the APAC MedTech Market
Posted on October 17, 202210/17/22
Developing Best-in-class Copay Programs for Gross-to-Net
Posted on October 12, 202210/12/22
The Evolution of HTA and Its Impact on Drug Prices in Japan
Posted on September 2, 20229/2/22
Plasma derived medicinal products – What is the way forward?
Posted on August 31, 20228/31/22
Single-Cell Multiomics: Opportunities, Challenges, and the Evolving Business Model
Posted on August 30, 20228/30/22